Generic Cos. Ask Fed. Circ. To Deny Amarin's Vascepa Appeal
The Federal Circuit should turn down Amarin Pharma Inc.'s appeal over its heart drug Vascepa, generic-drug makers have told the appeals court, saying Amarin is attempting to "manufacture legal error" where...To view the full article, register now.
Already a subscriber? Click here to view full article